Senior Analyst/Manager - Capital Assets at Eli Lilly and Company

Cork, County Cork, Ireland

Apply Now

Not SpecifiedCompensation

Senior (5 to 8 years)Experience Level

Full TimeJob Type

UnknownVisa

Pharmaceuticals, HealthcareIndustries

Requirements

3 years’ experience in Finance function or public accounting practice, preferably with in-depth knowledge of capital processes in a multinational environment as well as US GAAP/IFRS technical accounting
Accounting / Finance degree (Undergraduate or Masters as required for certification)
CPA, CIMA, ACCA, Chartered Accountant or equivalent
Fluency in English
Experience with SAP CA Module, Business Warehouse or Business Objects
MS Excel, Word and PowerPoint
Ability to handle complexity and utilize analytical skills, with attention to detail
Ability to proactively & effectively analyse & resolve problems in the Capital Assets area & devise appropriate testing strategies to support
Ability to effectively prioritize and complete key tasks and deliverables whilst demonstrating full ownership & accountability
Ability to respond flexibly and empathetically to customer needs, managing their expectations effectively
Ability to work in global team environment and communicate effectively with both internal business partners of all levels & disciplines, especially affiliate Project Managers outside of Finance as well as external Business Process Outsourced organisation team members

Responsibilities

Ensure the accurate capitalisation of all relevant assets as well as monitoring closely the Assets Under Construction throughout the EMEA region, with strict adherence to company policies while working closely with the European affiliates
Be seen as a “go-to” information resource for Capital Asset related queries
Review all Capitalisation Forms received to ensure they are in line with company policies and capitalized for the company closing calendar
Deliver training and support to Project Managers to ensure good quality Capitalisation Form submissions for assigned affiliates
Coordinate the physical inventory counts with the affiliate business partners
Ensure correct asset modifications in SAP (e.g. sales, write off, Master data change)
Prepare / Review account reconciliations in accordance with reconciliation methodology
Review key Capital Asset metrics & communicate to stakeholders to ensure key deliverables are being met whilst identifying and implementing initiatives to improve, including following up on late or inactive projects for assigned affiliates
Support global/regional Capital Assets projects
Support the overall Capital Assets team by demonstrating flexibility in providing cover for team members and training of new team members
Deliver training and support to affiliates to ensure good quality lease form submissions
Administering SAP Lease Administration (SLAN) for additions, modifications and retirement of leases
Maintain and perform SOx controls aligned with the process
Management of AUC, and capitalisation of projects for affiliates
Management of quarterly and annual tasks such as Physical Inventory, Master Data Management and Capital Investment Committee reporting
Collaborate closely with the General Accounting (GA) team to ensure the accuracy and completeness of the trial balance (TB) and financial reporting, understanding the impact of capital activities to ensure these are properly reflected in the financial statements

Skills

SAP

Capital Asset Management

Account Reconciliation

Physical Inventory

Asset Capitalization

Project Coordination

Stakeholder Communication

Metrics Analysis

Training Delivery

Policy Adherence

Eli Lilly and Company

Develops and delivers prescription medicines globally

About Eli Lilly and Company

Eli Lilly and Company is a global pharmaceutical company that focuses on discovering, developing, and delivering medicines to improve health. The company has a long history of scientific achievements, including the creation of insulin, the first life-saving treatment for diabetes. Lilly's operations involve extensive research and development to create new medications and enhance existing ones, ensuring they are safe and effective. Their products are primarily prescription medicines sold to healthcare providers for various medical conditions, including diabetes, cancer, and pain management. What sets Lilly apart from its competitors is its strong commitment to ethical practices and the protection of its products from counterfeiting. The company's goal is to enhance lives through innovative medical solutions while maintaining high standards of quality and ethics.

Indianapolis, IndianaHeadquarters

1876Year Founded

$1,180.1MTotal Funding

IPOCompany Stage

Biotechnology, HealthcareIndustries

10,001+Employees

Risks

Competition from Novo Nordisk's Ozempic may impact tirzepatide's market share.

Potential construction delays in Indiana could affect GLP-1 drug production timelines.

Regulatory challenges may hinder Kisunla's expansion in new Alzheimer's markets.

Differentiation

Eli Lilly's rich history includes the first life-saving insulin treatment.

Lilly's strategic partnerships enhance its position in neurodegenerative disease treatments.

FDA approval of Zepbound opens new therapeutic markets for sleep disorder treatments.

Upsides

Lilly's $9 billion complex in Indiana boosts GLP-1 drug production capacity.

Kisunla's approval in China expands Lilly's Alzheimer's treatment market in Asia.

Collaboration with EVA Pharma enhances Lilly's reputation as socially responsible.

Land your dream remote job 3x faster with AI

Try Jobo Free